The contribution of Bcl-2 to prostate cancer progression in in vitro and in vivo models
Elizabeth Bruckheimer(The University of Texas MD Anderson Cancer Center), Timothy J. McDonnell(Health Service Executive), N M Greenberg, Shawn Brisbay, Jeffrey R. Gingrich, Nancy L. Weigel(Baylor College of Medicine)
Proceedings of the American Association for Cancer Research Annual Meeting
October 9, 1999
Cited by 2
Related Papers
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
|Nature Medicine|2004|956
Molecular interactions of steroid hormone receptor with its enhancer element: Evidence for receptor dimer formation
|Cell|1988|598
Polyglutamine-Expanded Androgen Receptors Form Aggregates That Sequester Heat Shock Proteins, Proteasome Components and SRC-1, and Are Suppressed by the HDJ-2 Chaperone
|Human Molecular Genetics|1999|448
Androgen receptors in hormone-dependent and castration-resistant prostate cancer
|Pharmacology & Therapeutics|2013|441
Activation of the Human Androgen Receptor through a Protein Kinase A Signaling Pathway
|Journal of Biological Chemistry|1996|432